Incorporation of ¹⁴C-palmitate and ¹⁴C-acetate into triacylglycerol in <i>M</i>. <i>abscessus</i> is increased by NMP. by Timilehin Faboro (20175963)

Antibody reagent list. by Helena Saura Martinez (22305113)

“…In <i><i>T. bryosalmonae</i></i> exposed animals, parasite concentration increased significantly over time. Moreover, a proportional increase in IgM⁺ B cells and a proportional decrease in myeloid cells over time was observed. …”

Parameters for the treadmill during the acclimatization period. by Wenbin Wu (292223)

Subjects:

Improvement effect of lactoferrin and Coenzyme Q10 on body composition of mice with sarcopenia. by Wenbin Wu (292223)

Subjects:

KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia. by Wenbin Wu (292223)

Subjects:

Effects of lactoferrin and Coenzyme Q10 on skeletal muscle of mice. by Wenbin Wu (292223)

Subjects:

Each group’s performance on behavioral tests. by Wenbin Wu (292223)

Subjects:

Parameters for the treadmill during the testing phase. by Wenbin Wu (292223)

Subjects:

Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs. by Wenbin Wu (292223)

Subjects:

HE staining of the gastrocnemius muscle. by Wenbin Wu (292223)

Subjects:

qPCR verified the expression changes of GO and KEGG pathway enriched sarcopenia related DEGs. by Wenbin Wu (292223)

Subjects:

Baseline characteristics. by Seung Min Lee (1644409)

“…The distance of the FD decreased (<i>P</i> < 0.001) and FVs increased (<i>P</i> < 0.001, both). …”

Data file used in this study. by Seung Min Lee (1644409)

“…The distance of the FD decreased (<i>P</i> < 0.001) and FVs increased (<i>P</i> < 0.001, both). …”

Changes in foveal location after surgery. by Seung Min Lee (1644409)

“…The distance of the FD decreased (<i>P</i> < 0.001) and FVs increased (<i>P</i> < 0.001, both). …”

Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. by Jiefeng Zhao (9090305)

Subjects:

Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects: